Donald A. Bergstrom - Sep 27, 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Executive Vice President, Head of Research and Development
Signature
/s/ Brian Adams, as attorney-in-fact
Stock symbol
RLAY
Transactions as of
Sep 27, 2021
Transactions value $
-$23,818
Form type
4
Date filed
9/27/2021, 09:27 PM
Previous filing
Jun 30, 2021
Next filing
Oct 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$23.8K -646 -0.85% $36.87 75.6K Sep 27, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,187 shares of restricted stock units ("RSUs") on September 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 30,625 shares underlying RSUs.

Remarks:

Executive Vice President, Head of Research and Development